{"url_path":"/sec/pets/10-k/2026/item-15","section_key":"item-15","section_title":"Item 15 EXHIBITS AND FINANCIAL STATEMENT SCHEDULES","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1040130/0001040130-26-000019-index.html","accession_number":"0001040130-26-000019","cik":"0001040130","ticker":"PETS","issuer_name":"PETMED EXPRESS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1040130/0001040130-26-000019-index.html","primary_entity_key":"0001040130","primary_entity_name":"PETMED EXPRESS INC"},"word_count":1220,"has_tables":true,"body_markdown":"ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES\n\n(a)The following documents are filed as part of this Annual Report on Form 10-K.\n\n(1)Consolidated Financial Statements – See the Index to Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K.\n\nThe following exhibits are filed as part of this Annual Report on Form 10-K or hereby incorporated by reference to exhibits previously filed with the SEC.\n\n(3)Articles of Incorporation and By-Laws\n\n3.1\n[Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 to our Registration Statement on Form 10-SB, File No. 000-28827, filed January 10, 2000).](https://www.sec.gov/Archives/edgar/data/1040130/000104291000000023/0001042910-00-000023.txt)\n\n3.2\n[Articles of Amendment to the Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.2 to our Form 10-K for the year ended March 31, 2015, filed May 22, 2015).](https://www.sec.gov/Archives/edgar/data/1040130/000157104915004580/t82385_ex3-2.htm)\n\n3.3\n\n[Articles of Amendment to the Amended and Restated Articles of Incorporation, dated December 3, 2024 (incorporated by reference to Exhibit 3.1 to the Company’s](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000122/pets-articlesofamendmentto.htm)[Form 8-K](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000122/pets-articlesofamendmentto.htm)[/A](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000122/pets-articlesofamendmentto.htm)[filed](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000122/pets-articlesofamendmentto.htm)[December](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000122/pets-articlesofamendmentto.htm)[18](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000122/pets-articlesofamendmentto.htm)[, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000122/pets-articlesofamendmentto.htm)\n\n3.4\n[Third Amended and Restated By-Laws of PetMed Express, Inc. (incorporated by reference to Exhibit 3.3 to our Form 10-Q for the quarter ended September 30, 2024, filed November 7, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000117/pets-20240930xexx33thirdam.htm)\n\n(4)Instruments Defining the Rights of Security Holders\n\n4.1\n[Specimen common stock certificate (incorporated by reference to Exhibit 4.2 to our Registration Statement on Form 10-SB, File No. 000-28827, filed January 10, 2000).](https://www.sec.gov/Archives/edgar/data/1040130/000104291000000023/0001042910-00-000023.txt)\n\n4.2\n[Description of Securities.](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000072/pets-20250331xexx42.htm)[(incorporated by reference to Exhibit 4.2 to our Form 10-K filed November 14, 2025.](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000072/pets-20250331xexx42.htm)\n\n4.3\n\n[Rights Agreement, dated December 3, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as rights agent (which includes the Form of Right Certificate as Exhibit B thereto) (incorporated by reference to Exhibit 4.1 to the Form 8-K/A filed December 18, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000126/pets-shareholderrightsagre.htm)\n\n4.4\n[Amendment No. 1 to Rights Agreement, dated as of November 26, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as rights agent (incorporated by reference to Exhibit 4.2 to the For](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000091/exhibit42amendmentno1torig.htm)[m](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000091/exhibit42amendmentno1torig.htm)[8-K filed November 26, 2025).](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000091/exhibit42amendmentno1torig.htm)\n\n(10)Material Contracts\n\n10.1+\n[2016 Employee Equity Compensation Restricted Stock Plan, including form of Restricted Stock Agreement used for grants of restricted stock (incorporated by reference to Exhibit A to our definitive Proxy Statement for our 2016 Annual Meeting of Shareholders filed June 13, 2016).](https://www.sec.gov/Archives/edgar/data/1040130/000157104916015952/t1600385_def14a.htm)\n\n10.2 +\n[Form of Indemnification Agreement entered into with the Directors and Executive Officers of the Company (incorporated by reference to Exhibit 10.1 to our Form 10-Q for the quarter ended June 30, 2019, filed July 30, 2019).](https://www.sec.gov/Archives/edgar/data/1040130/000143774919014942/ex_151991.htm)\n\n10.3+\n[2022 Employee Equity Compensation Plan (as amended and restated) (incorporated by reference to Exhibit 10.1 to our Form 8-K filed June 20, 2023).](https://www.sec.gov/Archives/edgar/data/1040130/000104013023000040/a8k06152023-ex101.htm)\n\n10.3.1+\n[Form of Restricted Stock Unit Agreement under 2022 Employee Equity Compensation Plan (incorporated by reference to Exhibit 10.3 to our Form 8-K filed June 20, 2023).](https://www.sec.gov/Archives/edgar/data/1040130/000104013023000040/a8k061523-ex103.htm)\n\n10.3.2+\n[Form of Performance Stock Unit Agreement under 2022 Employee Equity Compensation Plan (incorporated by reference to Exhibit 10.4 to our Form 8-K filed June 20, 2023).](https://www.sec.gov/Archives/edgar/data/1040130/000104013023000040/a8k061523-ex104.htm)\n\n10.4+\n[2015 Outside Director Equity Compensation Plan (as amended and restated) (incorporated by reference to Exhibit 10.5 to our Form 8-K filed June 20, 2023).](https://www.sec.gov/Archives/edgar/data/1040130/000104013023000040/a8k06152023-ex105.htm)\n\n81\n\n[Table of Contents](#i5612d35ddc704c22b6b8aabf807e450f_7)\n\n10.4.1+\n[Form of Restricted Stock Unit Agreement under 2015 Outside Director Equity Compensation Plan (incorporated by reference to Exhibit 10.7 to our Form 8-K filed June 20, 2023).](https://www.sec.gov/Archives/edgar/data/1040130/000104013023000040/a8k06152023-ex107.htm)\n\n10.4.2+\n[Form of Restricted Stock Agreement under the 2015 Outside Director Equity Compensation Plan (incorporated by reference to Exhibit 10.10.1 to our Form 10-K for the year ended March 31, 2017 filed May 23, 2017).](https://www.sec.gov/Archives/edgar/data/1040130/000157104917005258/t1700341_ex10-10z1.htm)\n\n10.5+\n[Executive Employment Agreement, dated April 29, 2024, between the Company and Sandra Campos (incorporated by reference to Exhibit 10.2 to our Form 8-K filed on April 29,2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000022/pets-20240429xexx102.htm)\n\n10.5.1+\n[Separation Agreement, dated August 11, 2025, between the Company and Sandra Campos (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on August 12, 2025)](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000049/pets-camposexecseparationa.htm)\n\n10.6+\n[PetMed Express, Inc. 2024 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to our Form 8-K filed August 8, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000081/exhibit1012024omnibusincen.htm)\n\n10.6.1+\n\n[Form of Restricted Stock Unit Award under 2024 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1.1 to our Form 8-K filed August 8, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000081/exhibit1011formofrsuaward.htm)\n\n10.6.2+\n\n[Form of Performance Stock Unit Award under 2024 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1.2 to our Form 8-K filed August 8, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000081/exhibit1012formofpsuaward.htm)\n\n10.6.3+\n\n[Form of Restricted Stock Award under 2024 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1.3 to our Form 8-K filed August 8, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000081/exhibit1013formofrsa.htm)\n\n10.6.4+\n\n[Form of Stock Option Award under the 2024 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1.4 to our Form 8-K filed August 8, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000081/exhibit1014formofstockopti.htm)\n\n10.7+\n\n[Non-Employee Director Compensation Program, revised as of October 29, 2025.*](pets-20260331xex107.htm)\n\n10.8+\n[PetMed Express, Inc. 2024 Inducement Incentive Plan (incorporated by reference to Exhibit 10.1 to our Form 8-K filed September 27, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000110/exhibit1012024inducementin.htm)\n\n10.8.1+\n\n[Form of Restricted Stock Unit Award under 2024 Inducement Incentive Plan (incorporated by reference to Exhibit 10.1.1 to our Form 8-K filed September 27, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000110/exhibit1011formrsuaward.htm)\n\n10.8.2+\n\n[Form of Performance Stock Unit Award under 2024 Inducement Incentive Plan (incorporated by reference to Exhibit 10.1.2 to our Form 8-K filed September 27, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000110/exhibit1012formpsuaward.htm)\n\n10.8.3+\n\n[Form of Restricted Stock Award under 2024 Inducement Incentive Plan (incorporated by reference to Exhibit 10.1.3 to our Form 8-K filed September 27, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000110/exhibit1013formrsa.htm)\n\n10.8.4+\n\n[Form of Stock Option Award under the 2024 Inducement Incentive Plan (incorporated by reference to Exhibit 10.1.4 to our Form 8-K filed September 27, 2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000110/exhibit1014formofstockopti.htm)\n\n10.9+\n[Executive Employment Agreement, dated September 16, 2024, between the Company and Robyn D’Elia (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on September 12,2024).](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000095/pets-20240911xexx101employ.htm)\n\n10.9.1+\n[Separation Agreement, dated August 11, 2025, between the Company and Robyn D’Elia (incorporated by](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000049/pets-deliaexecseparationag.htm)[reference](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000049/pets-deliaexecseparationag.htm)[to Exhibit 10.2 to our Form 8-K filed on August 12, 2025](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000049/pets-deliaexecseparationag.htm)[).](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000049/pets-deliaexecseparationag.htm)\n\n10.10+\n[Change of Control and General Severance Agreement, dated November 26, 2025, between PetMed Express, Inc. and Douglas Krulik (incorporated by reference to Exhibit 10.1 to our Form 8-K filed November 26, 2025)](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000091/exhibit101changeofcontrola.htm)[.](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000091/exhibit101changeofcontrola.htm)\n\n10.11+\n[Interim Executive Employment Agreement, dated October 20, 2025, between the Company and Leslie C.G. Campbell (incorporated by reference to Exhibit 10.1 to our Form 10-K filed October 21, 2025).](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000077/pets-xcampbellemploymentag.htm)\n\n(19)     Insider trading policies and procedures\n\n19.1\n[Statement of Policy Regarding I](pets-20260331xexx191.htm)[nsider Trading](pets-20260331xexx191.htm)[*](pets-20260331xexx191.htm)\n\n82\n\n[Table of Contents](#i5612d35ddc704c22b6b8aabf807e450f_7)\n\n(21)Subsidiaries of Registrant\n\n21.1\n[Subsidiaries of Registrant](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000072/pets-20250331xexx211.htm)[(incorporated by reference to Exhibit 21.1 to our Form 10-K filed October 14, 2025)](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000072/pets-20250331xexx211.htm)\n\n(23)Consents of Experts and Counsel\n\n23.1\n[Consent of Baker Tilly LLP*](pets-20260331xexx231.htm)\n\n23.2\n[Consent of RSM US LLP*](pets-20260331xexx232.htm)\n\n(31)Certifications\n\n31.1\n[Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a)*](pets-20260331xexx311.htm)\n\n31.2\n[Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a)*](pets-20260331xexx312.htm)\n\n(32)Certifications\n\n32.1\n[Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 1350**](pets-20260331xexx321.htm)\n\n(97)    Policy Relating to Recovery of Erroneously Awarded Compensation\n\n97.1\n[Executive Compensation Recovery Policy](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000072/pets-20250331xexx971.htm)[(incorporated by reference to Exhibit 97.1 to our Form 10-K filed October 14, 2025)](https://www.sec.gov/Archives/edgar/data/1040130/000104013025000072/pets-20250331xexx971.htm)\n\n101.INS*Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)\n\n101.SCH*Inline XBRL Taxonomy Extension Schema Document\n\n101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document\n\n101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document\n\n101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document\n\n101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document\n\n104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)\n\n_______________________________\n\n*Filed herewith\n\n**Furnished herewith\n\n+ Indicates a management contract or compensatory plan or arrangement"}